Fragile X Syndrome and Targeted Treatment Trials (original) (raw)

• Allen K, Gleeson J et al (1998) PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 20:25–30
  Article PubMed CAS Google Scholar
• Alloway TP, Alloway RG (2010) Investigating the predictive roles of working memory and IQ in academic attainment. J Exp Child Psychol 106(1):20–29
  Article PubMed Google Scholar
• Amaria RN, Billeisen LL et al (2001) Medication use in fragile X syndrome. Mental Health Asp Dev Dis 4(4):143–147
  Google Scholar
• Antar L, Afroz R et al (2004) Metabotropic glutamate receptor activation regulates fragile X mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J Neurosci 24:2648–2655
  Article PubMed CAS Google Scholar
• Antar L, Li C et al (2006) Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol Cell Neurosci 32:37–48
  Article PubMed CAS Google Scholar
• Aschrafi A, Cunningham B et al (2005) The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc Natl Acad Sci USA 102:2180–2185
  Article PubMed CAS Google Scholar
• Backes M, Genç B et al (2000) Cognitive and behavioral profile of fragile X boys: correlations to molecular data. Am J Med Genet 95:150–156
  Article PubMed CAS Google Scholar
• Baddeley A (2000) The episodic buffer: a new component of working memory? Trends Cogn Sci 4(11):417–423
  Article PubMed Google Scholar
• Baker S, Hooper S et al (2011) Working memory subsystems and task complexity in young boys with Fragile X syndrome. J Intellect Disabil Res 55(1):19–29
  Article PubMed CAS Google Scholar
• Bakker C, D.-B. F. X. Consortium (1994) FMR1 knockout mice: a model to study fragile X mental retardation. Cell 78:23–33
  Google Scholar
• Barkley RA (1996) Attention-deficit=hyperactivity disorder. In: Mash EJ, Barkley RA (eds) Child psychopathology. Guilford, New York, pp 63–112
  Google Scholar
• Bassell GJ, Warren ST (2008) Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60(2):201–214
  Article PubMed CAS Google Scholar
• Bear MF, Huber KM et al (2004) The mGluR theory of fragile X mental retardation. Trends Neurosci 27(7):370–377
  Article PubMed CAS Google Scholar
• Beaulieu J, Caron M (2008) Looking at lithium: molecular moods and complex behaviour. Mol Interv 8:230–241
  Article PubMed CAS Google Scholar
• Beck SJ, Hanson CA et al (2010) A controlled trial of working memory training for children and adolescents with ADHD. J Clin Child Adolesc Psychol 39(6):825–836
  Article PubMed Google Scholar
• Belmonte MK, Bourgeron T (2006) Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci 9(10):1221–1225
  Article PubMed CAS Google Scholar
• Bent S, Hendren RL (2010) Improving the prediction of response to therapy in autism. Neurotherapeutics 7(3):232–240
  Article PubMed CAS Google Scholar
• Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361(6410):315–325
  Article PubMed CAS Google Scholar
• Berry-Kravis E, Ciurlionis R (1998) Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells. J Neurosci Res 51(1):41–48
  Article PubMed CAS Google Scholar
• Berry-Kravis E, Potanos K (2004) Psychopharmacology in fragile X syndrome – present and future. Ment Retard Dev Disabil Res Rev 10(1):42–48
  Article PubMed Google Scholar
• Berry-Kravis E, Hicar M et al (1995) Reduced cyclic AMP production in fragile X syndrome: cytogenetic and molecular correlations. Pediatr Res 38(5):638–643
  Article PubMed CAS Google Scholar
• Berry-Kravis E, Krause SE et al (2006) Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: A controlled trial. J Child Adolesc Psychopharmacol 16(5):525–540
  Article PubMed Google Scholar
• Berry-Kravis E, Sumis A et al (2008a) Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr 29(4):293–302
  Article PubMed Google Scholar
• Berry-Kravis E, Sumis A et al (2008b) Characterization of potential outcome measures for future clinical trials in fragile x syndrome. J Autism Dev Disord 38(9):1751–1757
  Article PubMed Google Scholar
• Berry-Kravis E, Hessl D et al (2009) A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet 46(4):266–271
  Article PubMed CAS Google Scholar
• Berry-Kravis E, Raspa M et al (2010) Seizures in fragile x syndrome: characteristics and comorbid diagnoses. Am J Intellect Dev Disabil 115(6):461–472
  Article PubMed Google Scholar
• Berry-Kravis E, Knox A et al (2011) Targeted treatments for fragile X syndrome. J Neurodev Disord 3(3):193–210
  Google Scholar
• Biederman J, Monuteaux MC et al (2004) Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol 72(5):757–766
  Article PubMed Google Scholar
• Bienvenu T, des Portes V et al (2000) Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am J Med Genet 93:294–298
  Article PubMed CAS Google Scholar
• Bilousova T, Rusakov D et al (2006) Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J Neurochem 97:44–56
  Article PubMed CAS Google Scholar
• Bilousova T, Dansie L et al (2009) Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 46:94–102
  Article PubMed CAS Google Scholar
• Bolduc F, Bell K et al (2008) Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nat Neurosci 11:1143–1145
  Article PubMed CAS Google Scholar
• Braun K, Segal M (2000) FMRP involvement in formation of synapses among cultured hippocampal neurons. Cereb Cortex 10:1045–1052
  Article PubMed CAS Google Scholar
• Bregman JD, Leckman JF et al (1988) Fragile X syndrome: Genetic predisposition to psychopathology. J Autism Dev Disord 18:343–354
  Article PubMed CAS Google Scholar
• Bschor T, Lewitzka U et al (2003) Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms. Pharmacopsychiatry 36(Suppl 3):S230–234
  PubMed CAS Google Scholar
• Castellanos FX, Tannock R (2002) Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 3(8):617–628
  PubMed CAS Google Scholar
• Chang S, Bray S et al (2008) Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 4:256–263
  Article PubMed CAS Google Scholar
• Chen L, Toth M (2001) Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103:1043–1050
  Article PubMed CAS Google Scholar
• Chen M, Ona V et al (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797–801
  Article PubMed CAS Google Scholar
• Chen LY, Rex CS et al (2010) Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome. J Neurosci 30(33):10977–10984
  Article PubMed CAS Google Scholar
• Choi Y, Kim H et al (2007) Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32:2393–2404
  Article PubMed CAS Google Scholar
• Choi CH, Schoenfeld BP et al (2010) Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment. Brain Res 1380:106–119. doi:10.1016/j.brainres.2010.1011.1032
  Article PubMed CAS Google Scholar
• Chonchaiya W, Schneider A et al (2009) Fragile x: a family of disorders. Adv Pediatr 56(1):165–186
  Article PubMed Google Scholar
• Chuang S, Zhao W et al (2005) Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J Neurosci 25:8048–8055
  Article PubMed CAS Google Scholar
• Cohen I (1995) Behavioral profiles of autistic and non autistic fragile X males. Dev Brain Dysfunct 8:252–269
  Google Scholar
• Comery T, Harris J et al (1997) Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 94:5401–5404
  Article PubMed CAS Google Scholar
• Conway AR, Kane MJ et al (2003) Working memory capacity and its relation to general intelligence. Trends Cogn Sci 7(12):547–552
  Article PubMed Google Scholar
• Cornish KM, Sudhalter V et al (2004a) Attention and language in fragile X. Ment Retard Dev Disabil Res Rev 10(1):11–16
  Article PubMed Google Scholar
• Cornish KM, Turk J et al (2004b) Annotation: deconstructing the attention deficit in fragile X syndrome: a developmental neuropsychological approach. J Child Psychol Psychiatry 45(6):1042–1053
  Article PubMed CAS Google Scholar
• Curia G, Papouin T et al (2008) Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cereb Cortex 19:1515–1520
  Article PubMed Google Scholar
• Dahlin K (2010) Effects of working memory training on reading in children with special needs. Read Writ. doi:10.1007/s11145-11010-19238-y
• Daneman M, Merikle P (1996) Working memory and language comprehension: a meta-analysis. Psychon Bull Rev 3(4):422–433
  Article Google Scholar
• Darnell JC, Fraser CE et al (2005) Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev 19(8):903–918
  Article PubMed CAS Google Scholar
• Darnell JC, SJ Van Driesche C et al (2011) FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism. Cell 146(2):247–261
  Google Scholar
• de Diego-Otero Y, Romero-Zerbo Y et al (2008) Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency. Neuropsychopharmacology 34:1011–1026
  Article PubMed CAS Google Scholar
• de Vries PJ (2010) Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. Neurotherapeutics 7(3):275–282
  Article PubMed Google Scholar
• de Vrij FM, Levenga J et al (2008) Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 31(1):127–132
  Article PubMed CAS Google Scholar
• Destot-Wong K, Liang K et al (2009) The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis. Neuropharmacology 57:277–286
  Article PubMed CAS Google Scholar
• D'Hooge R, Nagels G et al (1997) Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience 76(2):367–376
  Article PubMed Google Scholar
• D'Hulst C, De Geest N et al (2006) Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res 1121:238–245
  Article PubMed CAS Google Scholar
• Dobkin C, Rabe A et al (2000) Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience 100(2):423–429
  Article PubMed CAS Google Scholar
• Dölen G, Osterweil E et al (2007) Correction of fragile X syndrome in mice. Neuron 56:955–962
  Article PubMed CAS Google Scholar
• Du J, Wei Y et al (2010) A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors. Proc Natl Acad Sci USA 107(25):11573–11578
  Article PubMed CAS Google Scholar
• el Bekay R, Romero-Zerbo Y et al (2007) Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome. Eur J Neurosci 26:3169–3180
  Article PubMed Google Scholar
• El Idrissi A, Ding X et al (2005) Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. Neurosci Lett 377:141–146
  Article PubMed CAS Google Scholar
• El Idrissi A, Boukarrou L et al (2009) Taurine improves congestive functions in a mouse model of fragile X syndrome. Adv Exp Med Biol 643:191–198
  Article PubMed CAS Google Scholar
• Engel PM, Santos FH et al (2008) Are working memory measures free of socioeconomic influence? J Speech Lang Hear Res 51(6):1580–1587
  Article PubMed Google Scholar
• Erickson CA, Mullett JE et al (2009) Open-label memantine in fragile X syndrome. J Autism Dev Disord 39:1629–1635
  Google Scholar
• Erickson CA, Mullett JE et al (2010a) Brief report: acamprosate in fragile X syndrome. J Autism Dev Disord 40(11):1412–1416
  Article PubMed Google Scholar
• Erickson CA, Stigler KA et al (2010b) Aripiprazole in autism spectrum disorders and fragile X syndrome. Neurotherapeutics 7(3):258–263
  Article PubMed CAS Google Scholar
• Erickson CA, Weng N et al (2010c) Open-label riluzole in fragile X syndrome. Brain Res. doi:10.1016/j.brainres.2010.1010.1108
• Farzin F, F Scaggs, et al (2011) Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome. J Autism Dev Disord. DOI: 10.1007/s10803-011-1176-2
  Google Scholar
• Fatemi SH, Folsom TD (2010) The role of fragile X mental retardation protein in major mental disorders.". Neuropharmacology 60:1221–1226
  Article PubMed CAS Google Scholar
• Fatemi SH, Kneeland RE et al (2010) Fragile X mental retardation protein levels are decreased in major psychiatric disorders. Schizophr Res 124(1–3):246–247
  Article PubMed Google Scholar
• Frankland P, Wang Y et al (2004) Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 9:417–425
  Article PubMed CAS Google Scholar
• Freund LS, Reiss AL et al (1993) Psychiatric disorders associated with fragile X in the young female. Pediatrics 91(2):321–329
  PubMed CAS Google Scholar
• Fry AF, Hale S (2000) Relationships among processing speed, working memory, and fluid intelligence in children. Biol Psychol 54(1–3):1–34
  Article PubMed CAS Google Scholar
• Fulks JL, O'Bryhim BE et al (2010) Dopamine release and uptake impairments and behavioral alterations observed in mice that model fragile x mental retardation syndrome. ACS Chem Neurosci 1(10):679–690
  Article PubMed CAS Google Scholar
• Gallagher S, Daly C et al (2004) Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1. J Neurosci 24:4859–4864
  Article PubMed CAS Google Scholar
• Gantois I, Bakker C et al (2001) Restoring the phenotype of fragile X syndrome: insight from the mouse model. Curr Mol Med 1:447–455
  Article PubMed CAS Google Scholar
• Gantois I, Vandesompele J et al (2006) Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis 21:346–357
  Article PubMed CAS Google Scholar
• Garstang J, Wallis M (2006) Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 32(5):585–589
  Article PubMed CAS Google Scholar
• Gasparini F, Lingenhöhl K et al (1999) 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38:1493–1503
  Article PubMed CAS Google Scholar
• Gathercole SE, Pickering SJ (2000) Working memory deficits in children with low achievements in the national curriculum at 7 years of age. Br J Educ Psychol 70(Pt 2):177–194
  Article PubMed Google Scholar
• Gathercole SE, Brown L et al (2003) Working memory assessments at school entry as longitudinal predictors of National Curriculum attainment levels. Educ Child Psychol 20:109–122
  Google Scholar
• Geary DC, Hoard MK et al (2004) Strategy choices in simple and complex addition: Contributions of working memory and counting knowledge for children with mathematical disability. J Exp Child Psychol 88(2):121–151
  Article PubMed Google Scholar
• Gold AB, Herrmann N et al (2010) Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae. Curr Drug Targets 12:243–255
  Article Google Scholar
• Grauer S, Marquis K (1999) Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague–Dawley rats. Psychopharmacology (Berl) 141:405–412
  Article CAS Google Scholar
• Gray JR, Chabris CF et al (2003) Neural mechanisms of general fluid intelligence. Nat Neurosci 6(3):316–322
  Article PubMed CAS Google Scholar
• Griffin MO, Ceballos G et al (2010) Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action. Pharmacol Res. doi:10.1016/j.phrs.2010.1010.1004
• Gross C, Nakamoto M et al (2010) Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci 30:10624–10638
  Article PubMed CAS Google Scholar
• Grossman A, Elisseou N et al (2006) Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. Brain Res 1084:158–164
  Article PubMed CAS Google Scholar
• Gruss M, Braun K (2004) Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice. Neurochem Int 45:81–88
  Article PubMed CAS Google Scholar
• Gunther VK, Schafer P et al (2003) Long-term improvements in cognitive performance through computer-assisted cognitive training: a pilot study in a residential home for older people. Aging Ment Health 7(3):200–206
  Article PubMed CAS Google Scholar
• Hagerman R, Silverman A (1991) Fragile X syndrome. Diagnosis, treatment, and research. Johns Hopkins University Press, Baltimore, MD
  Google Scholar
• Hagerman RJ, Murphy MA et al (1988) A controlled trial of stimulant medication in children with the fragile X syndrome. Am J Med Genet 30(1–2):377–392
  Article PubMed CAS Google Scholar
• Hagerman RJ, Fulton MJ et al (1994) A survey of fluoxetine therapy in fragile X syndrome. Dev Brain Dysfunct 7:155–164
  Google Scholar
• Hagerman RJ, Berry-Kravis E et al (2009) Advances in the treatment of fragile X syndrome. Pediatrics 123(1):378–390
  Article PubMed Google Scholar
• Hagerman RJ, Hoem G et al (2010) Fragile X and autism: intertwined at the molecular level leading to targeted treatments. Mol Autism 1(1):12
  Article PubMed CAS Google Scholar
• Hardeland R (2010) Investigational melatonin receptor agonists. Expert Opin Investig Drugs 19:747–764
  Article PubMed CAS Google Scholar
• Hayashi M, Choi S et al (2004) Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice. Neuron 42:773–787
  Article PubMed CAS Google Scholar
• Hayashi M, Rao B et al (2007) Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci USA 104:11489–11494
  Article PubMed CAS Google Scholar
• Hessl D, Berry-Kravis E et al (2008) Prepulse inhibition in fragile X syndrome: Feasibility, reliability, and implications for treatment. Am J Med Genet B Neuropsychiatr Genet. doi:10.1002/ajmg.b.30858
• Hessl D, Maltas S et al (2010) Toward a fragile X behavior rating scale: the aberrant behavior checklist collaborative study [abstract]. 12th International Fragile X Conference; July 21st, Detroit, MI
  Google Scholar
• Hinton V, Brown W et al (1991) Analysis of neocortex in three males with fragile X syndrome. Am J Med Genet 41:289–294
  Article PubMed CAS Google Scholar
• Hjalgrim H, Jacobsen TB et al (1999) Frontal-subcortical hypofunction in the fragile X syndrome [letter]. Am J Med Genet 83(2):140–141
  Article PubMed CAS Google Scholar
• Holmes J, Gathercole SE et al (2009) Adaptive training leads to sustained enhancement of poor working memory in children. Dev Sci 12(4):F9–15
  Article PubMed Google Scholar
• Holmes J, Gathercole SE et al (2010) Working memory deficits can be overcome: impacts of training and medication on working memory in children with ADHD. Appl Cogn Psychol 24:827–836
  Article Google Scholar
• Hou L, Klann E (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 24:6352–6361
  Article PubMed CAS Google Scholar
• Hou L, Antion M et al (2006) Dynamic translational and proteasomal regulation of Fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51:441–454
  Article PubMed CAS Google Scholar
• Huber K, Kayser M et al (2000) Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288:1254–1257
  Article PubMed CAS Google Scholar
• Huber K, Gallagher S et al (2002) Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99:7746–7750
  Article PubMed CAS Google Scholar
• Ingvar M, Ambros-Ingerson J et al (1997) Enhancement by an ampakine of memory encoding in humans. Exp Neurol 146:553–559
  Article PubMed CAS Google Scholar
• Irwin S, Patel B et al (2001) Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet 98:161–167
  Article PubMed CAS Google Scholar
• Irwin S, Idupulapati M et al (2002) Dendritic spine and dendritic field characteristics on layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am J Med Genet 111:140–146
  Article PubMed Google Scholar
• Jacquemont S, Curie A et al (2011) Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 3(64):64ra61
  Article CAS Google Scholar
• Jaeggi SM, Buschkuehl M et al (2008) Improving fluid intelligence with training on working memory. Proc Natl Acad Sci USA 105(19):6829–6833
  Article PubMed CAS Google Scholar
• Jourdi H, Hamo L et al (2009a) BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices. Neuropharmacology 56:876–885
  Article PubMed CAS Google Scholar
• Jourdi H, Hsu YT et al (2009b) Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation. J Neurosci 29(27):8688–8697
  Article PubMed CAS Google Scholar
• Kane MJ, Engle RW (2002) The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychon Bull Rev 9(4):637–671
  Article PubMed Google Scholar
• Kane MJ, Hambrick DZ et al (2005) Working memory capacity and fluid intelligence are strongly related constructs: comment on Ackerman, Beier, and Boyle (2005). Psychol Bull 131(1):66–71, author reply 72–65
  Article PubMed Google Scholar
• Karr L, Pan Y et al (2010) CB1 receptor antagonism impairs the induction of epileptiform activity by group I metabotropic glutamate receptor activation. Epilepsia 51(suppl 3):121–125
  Article PubMed CAS Google Scholar
• Kelleher RJ 3rd, Bear MF (2008) The autistic neuron: troubled translation? Cell 135(3):401–406
  Article PubMed CAS Google Scholar
• Kelley DJ, Davidson RJ et al (2007) The cyclic AMP cascade is altered in the fragile X nervous system. PLoS One 2(9):e931
  Article PubMed CAS Google Scholar
• Kim SH, Markham JA et al (2008) Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome. Proc Natl Acad Sci USA 105(11):4429–4434
  Article PubMed CAS Google Scholar
• Klingberg T (2009) The overflowing brain: information overload and the limits of working memory. Oxford University Press, New York, NY
  Google Scholar
• Klingberg T (2010) Training and plasticity of working memory. Trends Cogn Sci 14(7):317–324
  Article PubMed Google Scholar
• Klingberg T, Forssberg H et al (2002) Training of working memory in children with ADHD. J Clin Exp Neuropsychol 24(6):781–791
  Article PubMed Google Scholar
• Klingberg T, Fernell E et al (2005) Computerized training of working memory in children with ADHD–a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 44(2):177–186
  Article PubMed Google Scholar
• Knox A, Berry-Kravis E (2009) Feasibility and reproducibility of the Tests of Attentional Performance for Children (KiTAP) in Fragile X Syndrome (FXS). Ann Neurol 66:S108
  Google Scholar
• Koekkoek S, Yamaguchi K et al (2005) Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron 47:339–352
  Article PubMed CAS Google Scholar
• Kooy R, D'Hooge R et al (1996) Transgenic mouse model for the fragile X syndrome. Am J Med Genet 64:241–245
  Article PubMed CAS Google Scholar
• Kooy F, Heulens I et al (2010) The GABAA receptor as a potential target for therapy of the fragile X syndrome [abstract]. NFXF 12th International FX Conference, Detroit, MI
  Google Scholar
• Kramar EA, Chen LY et al (2010) BDNF upregulation rescues synaptic plasticity in middle-aged ovariectomized rats. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2010.1006.1008
• Kramár E, Lin B et al (2004) A novel mechanism for the facilitation of theta-induced long-term potentiation by brain-derived neurotrophic factor. J Neurosci 24:5151–5161
  Article PubMed CAS Google Scholar
• Kremen WS, Jacobsen KC et al (2007) Genetics of verbal working memory processes: a twin study of middle-aged men. Neuropsychology 21(5):569–580
  Article PubMed Google Scholar
• Kronk R, Bishop EE et al (2010) Prevalence, nature, and correlates of sleep problems among children with fragile X syndrome based on a large scale parent survey. Sleep 33(5):679–687
  PubMed Google Scholar
• Kwon H, Menon V et al (2001) Functional neuroanatomy of visuospatial working memory in fragile X syndrome: relation to behavioral and molecular measures. Am J Psychiatry 158(7):1040–1051
  Article PubMed CAS Google Scholar
• Kyllonen P, Christal R (1990) Reasoning ability is (little more than) working memory capacity?! Intelligence 14:389–433
  Article Google Scholar
• Lanfranchi S, Cornoldi C et al (2009) Working memory in individuals with fragile X syndrome. Child Neuropsychol 15(2):105–119
  Article PubMed Google Scholar
• Larson J, Jessen R et al (2005) Age-dependent and selective impairment of long-term potentiation in the anterior piriform cortex of mice lacking the fragile X mental retardation protein. J Neurosci 25:9460–9469
  Article PubMed CAS Google Scholar
• Larson J, Kim D et al (2008) Olfactory discrimination learning in mice lacking the fragile X mental retardation protein. Neurobiol Learn Mem 90:90–102
  Article PubMed CAS Google Scholar
• Lauterborn J, Gall C (2004) Ampakines increase hippocampal and neocortical BDNF expression in a mouse model of Fragile X in vitro. Soc Neurosci Abst 116:13
  Google Scholar
• Lauterborn JC, Lynch G et al (2000) Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J Neurosci 20:8–21
  PubMed CAS Google Scholar
• Lauterborn J, Troung G et al (2003) Chronic elevation of brain-derived neurotrophic factor by ampkaines. J Pharmacol Exp Ther 307:297–305
  Article PubMed CAS Google Scholar
• Lauterborn J, Rex C et al (2007) Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J Neurosci 27:10685–10694
  Article PubMed CAS Google Scholar
• Lauterborn J, Pineda E et al (2009) Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression. Neuroscience 159:283–295
  Article PubMed CAS Google Scholar
• Lee A, Li W et al (2003) Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1. Dev Dis 130:5543–5552
  CAS Google Scholar
• Legutko B, Li X et al (2001) Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator. Neuropharmacology 40:1019–1027
  Article PubMed CAS Google Scholar
• Li J, Pelletier MR et al (2002) Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol Cell Neurosci 19:138–151
  Article PubMed CAS Google Scholar
• Liu ZH, Chuang DM et al (2010) Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.". Int J Neuropsychopharmacol 14:618–630
  Article PubMed CAS Google Scholar
• Louhivuori V, Vicario A et al (2011) BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse. Neurobiol Dis 41:469–480
  Article PubMed CAS Google Scholar
• Luciana M, Depue R et al (1992) Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci 4(1):58–68
  Article Google Scholar
• Luo Y, Shan G et al (2010) Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells. PLoS Genet 6(4):e1000898
  Article PubMed CAS Google Scholar
• Lynch G, Gall CM (2006) Ampakines and the threefold path to cognitive enhancement. Trends Neurosci 29(10):554–562
  Article PubMed CAS Google Scholar
• Lynch G, Kramar EA et al (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J Neurosci 27(16):4424–4434
  Article PubMed CAS Google Scholar
• Maezawa I, Jin LW (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30(15):5346–5356
  Article PubMed CAS Google Scholar
• Martinussen R, Hayden J et al (2005) A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 44(4):377–384
  Article PubMed Google Scholar
• Mastergeorge AM, Au J et al (2010) Fragile X: a family of disorders. In: Nass R, Frank Y (eds) Cognitive and behavioral abnormalities of pediatric diseases. Oxford University Press, New York, pp 170–187
  Google Scholar
• Mazzocco MMM, Baumgardner T et al (1998) Social functioning among girls with fragile X or Turner syndrome and their sisters. J Autism Dev Disord 28(6):509–517
  Article PubMed CAS Google Scholar
• McBride S, Choi C et al (2005) Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a model of fragile X syndrome. Neuron 45:753–764
  Article PubMed CAS Google Scholar
• McDonnell MN, Orekhov Y et al (2007) Suppression of LTP-like plasticity in human motor cortex by the GABAB receptor agonist baclofen. Exp Brain Res 180(1):181–186
  Article PubMed CAS Google Scholar
• McFarlane H, Kusek G et al (2008) Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav 7:152–163
  Article PubMed CAS Google Scholar
• McMillin D, Ooi M et al (2009) Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. Cancer Res 69:5835–5842
  Article PubMed CAS Google Scholar
• McNab F, Varrone A et al (2009) Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science 323(5915):800–802
  Article PubMed CAS Google Scholar
• McNaughton C, Moon J et al (2008) Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. Behav Neurosci 122:293–300
  Article PubMed Google Scholar
• Meredith R, Holmgren C et al (2007) Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1. Neuron 54:627–638
  Article PubMed CAS Google Scholar
• Meredith R, de Jong R et al (2011) Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse. Neurobiol Dis 41:104–110
  Article PubMed CAS Google Scholar
• Miller GA (1956) The magical number seven plus or minus two: some limits on our capacity for processing information. Psychol Rev 63(2):81–97
  Article PubMed CAS Google Scholar
• Miller L, McIntosh D et al (1999) Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet 83:268–279
  Article PubMed CAS Google Scholar
• Min WW, Yuskaitis CJ et al (2009) Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential. Neuropharmacology 56(2):463–472
  Article PubMed CAS Google Scholar
• Mines M, Yuskaitis C et al (2010) GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile x syndrome and autism. PLoS One 5:e9706
  Article PubMed CAS Google Scholar
• Mineur YS, Sluyter F et al (2002) Behavorial and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 12:39–46
  Article PubMed Google Scholar
• Mineur Y, Huynh L et al (2006) Social behavior deficits in the Fmr1 mutant mouse. Behav Brain Res 168:172–175
  Article PubMed CAS Google Scholar
• Minichiello L (2009) TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 10:850–860
  Article PubMed CAS Google Scholar
• Muddashetty R, Kelić S et al (2007) Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J Neurosci 27:5338–5348
  Article PubMed CAS Google Scholar
• Müller D, von Cramon Y et al (1998) D1- versus D2-receptor modulation of visuospatial working memory in humans. J Neurosci 18:2720–2728
  PubMed Google Scholar
• Munir F, Cornish KM et al (2000) A neuropsychological profile of attention deficits in young males with fragile X syndrome. Neuropsychologia 38(9):1261–1270
  Article PubMed CAS Google Scholar
• Musumeci S, Hagerman R et al (1999) Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40:1092–1099
  Article PubMed CAS Google Scholar
• Musumeci S, Calabrese G et al (2007) Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes. Exp Neurol 203:233–240
  Article PubMed CAS Google Scholar
• Nakamoto M, Nalavadi V et al (2007) Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc Natl Acad Sci USA 104:15537–15542
  Article PubMed CAS Google Scholar
• National Institute of Child Health and Human Development, Office of Rare Disease Research, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke (2009) Outcome measures for clinical trials in children with Fragile X syndrome – meeting summary. Bethesda Marriott Pooks Hill, Bethesda, MD. http://rarediseases.info.nih.gov/ScientificConferences.aspx?PageID=5&ID=989
• Niaz M, Logie RH (1993) Working memory, mental capacity and science education: towards an understanding of the 'working memory overload hypothesis'. Oxf Rev Educ 19(4):511–525
  Article Google Scholar
• Nosyreva E, Huber K (2006) Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. J Neurophysiol 95:3291–3295
  Article PubMed CAS Google Scholar
• Olesen PJ, Westerberg H et al (2004) Increased prefrontal and parietal activity after training of working memory. Nat Neurosci 7(1):75–79
  Article PubMed CAS Google Scholar
• Olmos-Serrano J, Paluszkiewicz S et al (2010) Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci 30:9929–9938
  Article PubMed CAS Google Scholar
• Owen R, Gordon-Weeks PR (2003) Inhibition of glycogen synthase kinase 3beta in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones. Mol Cell Neurosci 23(4):626–637
  Article PubMed CAS Google Scholar
• Pacey L, Heximer S et al (2009) Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures. Mol Pharmacol 76:18–24
  Article PubMed CAS Google Scholar
• Paradee W, Melikian HE et al (1999) Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 94(1):185–192
  Article PubMed CAS Google Scholar
• Paribello C (2010) Open label add on treatment trial of minocycline in patients with fragile X syndrome [abstract]. FRAXA investigators meeting Durham, NH
  Google Scholar
• Paylor R (2008) Pharmacological modification of behavioral responses in the fragile X mouse model [abstract]. 11th International Fragile X Conference St. Louis, Missouri
  Google Scholar
• Peier A, McIlwain K et al (2000) (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet 9:1145–1159
  Article PubMed CAS Google Scholar
• Pinto D, Pagnamenta AT et al (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466(7304):368–372
  Article PubMed CAS Google Scholar
• Qin M, Kang J et al (2005) A null mutation for Fmr1 in female mice: effects on regional cerebral metabolic rate for glucose and relationship to behavior. Neuroscience 135(3):999–1009
  Article PubMed CAS Google Scholar
• Qiu L, Lu T et al (2009) Limbic epileptogenesis in a mouse model of fragile X syndrome. Cereb Cortex 19:1504–1514
  Article PubMed Google Scholar
• Rauen KA, Schoyer L et al (2010) Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. Am J Med Genet A 152A(1):4–24
  Article PubMed Google Scholar
• Restivo L, Ferrari F et al (2005) Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc Natl Acad Sci USA 102:11557–11562
  Article PubMed CAS Google Scholar
• Rex CS, Lauterborn JC et al (2006) Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor. J Neurophysiol 96(2):677–685
  Article PubMed CAS Google Scholar
• Rex C, Chen L et al (2009) Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. J Cell Biol 186:85–97
  Article PubMed CAS Google Scholar
• Richdale AL (1999) Sleep problems in autism: prevalence, cause, and intervention. Dev Med Child Neurol 41(1):60–66
  Article PubMed CAS Google Scholar
• Richdale A (2003) A descriptive analysis of sleep behaviour in children with fragile X. J Intellect Dev Disabil 28:135–144
  Article Google Scholar
• Romero-Zerbo Y, Decara J et al (2009) Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome. J Pineal Res 46(2):224–234
  Article PubMed CAS Google Scholar
• Rudelli R, Brown W et al (1985) Adult fragile X Syndrome. Clinico-neuropathologic findings. Acta Neuropathol 67:289–295
  Article PubMed CAS Google Scholar
• Rueda N, Florez J et al (2008) Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome. Neurosci Lett 433(1):22–27
  Article PubMed CAS Google Scholar
• Sabaratnam M, Vroegop P et al (2001) Epilepsy and EEG findings in 18 males with fragile X syndrome. Seizure 10:60–63
  Article PubMed CAS Google Scholar
• Selby L, Zhang C et al (2007) Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci Lett 412:227–232
  Article PubMed CAS Google Scholar
• Shang Y, Wang H et al (2009) Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice. J Neurochem 111:635–646
  Article PubMed CAS Google Scholar
• Sharma A, Hoeffer C et al (2010) Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30:694–702
  Article PubMed CAS Google Scholar
• Silverman J, Tolu S et al (2010) Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 35:976–989
  Article PubMed CAS Google Scholar
• Simmons D, Rex C et al (2009) Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc Natl Acad Sci USA 106:4906–4911
  Article PubMed CAS Google Scholar
• Singhal NK, Srivastava G et al (2010) Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse. J Pineal Res. doi:10.1111/j.1600-1079X.2010.00819.x
• Solanto M (2002) Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130:65–71
  Article PubMed CAS Google Scholar
• Spearman C (1927) Psychology down the ages. Macmillan, London
  Google Scholar
• Staubli U, Perez Y et al (1994a) Centrally active modulators of glutamate (AMPA) receptors facilitate the induction of LTP in vivo. Proc Natl Acad Sci USA 91:11158–11162
  Article PubMed CAS Google Scholar
• Staubli U, Rogers G et al (1994b) Facilitation of glutamate receptors enhances memory. Proc Natl Acad Sci USA 91:777–781
  Article PubMed CAS Google Scholar
• Suß H, Oberauer K et al (2002) Working-memory capacity explains reasoning ability – and a little bit more. Intelligence 20:261–288
  Article Google Scholar
• Suvrathan A, Hoeffer C et al (2010) Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA 107:11591–11596
  Article PubMed CAS Google Scholar
• Swanson HL, Sachse-Lee C (2001a) Mathematical problem solving and working memory in children with learning disabilities: both executive and phonological processes are important. J Exp Child Psychol 79(3):294–321
  Article PubMed CAS Google Scholar
• Swanson HL, Sachse-Lee C (2001b) A subgroup analysis of working memory in children with reading disabilities: domain-general or domain-specific deficiency? J Learn Disabil 34(3):249–263
  Article PubMed CAS Google Scholar
• Torrioli MG, Vernacotola S et al (2008) A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys. Am J Med Genet A 146(7):803–812
  PubMed Google Scholar
• Turk J (1998) Fragile X syndrome and attentional deficits. J Appl Res Intellect Disabil 11:175–191
  Article Google Scholar
• Ure J, Baudry M et al (2006) Metabotropic glutamate receptors and epilepsy. J Neurol Sci 247:109
  Article CAS Google Scholar
• Utari A, Chonchaiya W et al (2010) Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures. Am J Intellect Dev Disabil 115(5):433–443
  Article PubMed Google Scholar
• van Galen EJ, Ramakers GJ (2005) Rho proteins, mental retardation and the neurobiological basis of intelligence. Prog Brain Res 147:295–317
  Article PubMed CAS Google Scholar
• van't Hooft I, Andersson K et al (2003) Attention and memory training in children with acquired brain injuries. Acta Paediatr 92(8):935–940
  Article PubMed Google Scholar
• Venkitaramani DV, Aldridge GM et al (2010) Rescue of fragile X syndrome metabolic and behavioral phenotypes by lithium [abstract]. Society for Neuroscience, San Diego, CA, Abstr #: 757.12
  Google Scholar
• Ventura R, Pascucci T et al (2004) Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol 15:433–442
  Article PubMed CAS Google Scholar
• Volk L, Pfeiffer B et al (2007) Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation. J Neurosci 27:11624–11634
  Article PubMed CAS Google Scholar
• Vollrath B, Duron S et al (2010) Developing inhibitors of p21-activated kinase (PAK) for the treatment of Fragile X mental retardation. Soc Neurosci Abst 757.2
  Google Scholar
• Wada A (2009) Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci 110:14–28
  Article PubMed CAS Google Scholar
• Wang H, Wu L et al (2008a) FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 59:634–647
  Article PubMed CAS Google Scholar
• Wang H, Wu LJ et al (2008b) Roles of calcium-stimulated adenylyl cyclase and calmodulin-dependent protein kinase IV in the regulation of FMRP by group I metabotropic glutamate receptors. J Neurosci 28(17):4385–4397
  Article PubMed CAS Google Scholar
• Wang H, Kim S et al (2010a) Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization. J Biol Chem 285:21888–21901
  Article PubMed CAS Google Scholar
• Wang LW, Berry-Kravis E et al (2010b) Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 7(3):264–274
  Article PubMed CAS Google Scholar
• Wang L, Berry-Kravis E et al (in press) Arbaclofen treatment is associated with global behavioral improvement in fragile X syndrome (FXS: results of a randomized, controlled phase II trial. J Dev Behav Pediatr
  Google Scholar
• Waung M, Huber K (2009) Protein translation in synaptic plasticity: mGluR-LTD, Fragile X. Curr Opin Neurobiol 19:319–326
  Article PubMed CAS Google Scholar
• Weiler I, Irwin S et al (1997) Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395–5400
  Article PubMed CAS Google Scholar
• Weiler I, Spangler C et al (2004) Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc Natl Acad Sci USA 101:17504–17509
  Article PubMed CAS Google Scholar
• Weng N, Weiler IJ et al (2008) Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet 147B(7):1253–1257
  Article PubMed CAS Google Scholar
• Westerberg H, Klingberg T (2007) Changes in cortical activity after training of working memory – a single-subject analysis. Physiol Behav 92(1–2):186–192
  Article PubMed CAS Google Scholar
• Wilson B, Cox C (2007) Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Proc Natl Acad Sci USA 104:2454–2459
  Article PubMed CAS Google Scholar
• Wirojanan J, Jacquemont S et al (2009) The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med 5(2):145–150
  PubMed Google Scholar
• Wisniewski K, Segan S et al (1991) The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet 38:476–480
  Article PubMed CAS Google Scholar
• Yan QJ, Asafo-Adjei PK et al (2004) A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav 3(6):337–359
  Article PubMed CAS Google Scholar
• Yan Q, Rammal M et al (2005) Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.". Neuropharmacology 49:1053–1066
  Article PubMed CAS Google Scholar
• Yuskaitis C, Beurel E et al (2010a) Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochim Biophys Acta 1802:1006–1012
  Article PubMed CAS Google Scholar
• Yuskaitis C, Mines M et al (2010b) Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochem Pharmacol 79:632–646
  Article PubMed CAS Google Scholar
• Zalfa F, Eleuteri B et al (2007) A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 10(5):578–587
  Article PubMed CAS Google Scholar
• Zeier Z, Kumar A et al (2009) Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome. Gene Ther 16:1122–1129
  Article PubMed CAS Google Scholar
• Zhao W, Bianchi R et al (2004) Extracellular signal-regulated kinase 1/2 is required for the induction of group I metabotropic glutamate receptor-mediated epileptiform discharges. J Neurosci 24:76–84
  Article PubMed CAS Google Scholar
• Zhao M, Toyoda H et al (2005) Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J Neurosci 25:7385–7392
  Article PubMed CAS Google Scholar